Orilissa (elagolix) / Neurocrine, AbbVie  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Orilissa (elagolix) / AbbVie
NCT01403038: An Open-label Study of the Effects of Elagolix in Adult Premenopausal Females

Completed
1
216
US
Elagolix, ABT-620, elagolix sodium, elagolix
AbbVie (prior sponsor, Abbott), Neurocrine Biosciences
Folliculogenesis
10/12
11/12
NCT04445025: Comparison Elagolix vs Depot Leuprolide Prior to Frozen Embryo Transfers in Patients With Endometriosis

Completed
1
30
US
Elagolix 200 MG, Leuprolide Acetate 3.75 MG/ML, Lab work
Colorado Center for Reproductive Medicine, AbbVie
Infertility, Endometriosis
09/24
12/24
NCT03746535: Cardiovascular Disease Risk in Women With Endometriosis

Recruiting
1
40
US
Elagolix
Yale University, National Heart, Lung, and Blood Institute (NHLBI)
Endometriosis
12/25
12/26

Download Options